Most with Alzheimer’s disease, mild cognitive impairment would have been excluded from aducanumab...
Sep 16, 2021
Overall, 92.2, 91, and 85.5% of Medicare beneficiaries with Alzheimer’s disease-related disorders, Alzheimer’s disease, and mild cognitive impairment met at least one of the exclusion criteria.
Walnut intake linked to modest decrease in LDL cholesterol in seniors
Aug 30, 2021
Significant decreases were seen in total cholesterol, LDL-C and intermediate density lipoprotein cholesterol, with no increase in weight.
Risk for Bell’s palsy up 42 days after first dose of CoronaVac
Aug 25, 2021
A Hong Kong study shows small increased risk after the Sinovac Biotech vaccine known as CoronoVac, but no significantly increased risk after the BNT162b2 vaccine (Fosun-BioNTech [equivalent to Pfizer-BioNTech]).
FDA tells vaccine makers to update boosters to target omicron subvariants
Jun 30, 2022
Pfizer and Moderna are expected to start producing reformulated doses this summer.
Mounjaro approved for blood glucose control in type 2 diabetes
May 20, 2022
The once-weekly injection is approved as an addition to diet and exercise.
Interventions for Alzheimer’s disease improve cognition in men, women
May 03, 2022
Individualized multidomain interventions are equally effective for improving cognition in women and men.
Biden urges calm during omicron surge
Jan 05, 2022
Biden also announced that his administration is doubling its order of Pfizer’s new antiviral pill.
Glucose-lowering therapy delayed for patients with newly diagnosed type 2 diabetes
Jul 06, 2021
For adults in whom type 2 diabetes mellitus (T2DM) is newly diagnosed, delays to first-line therapy are longest for older patients, those who are Black or of other ethnicities, and those with multimorbidity,...
Biden pushes vaccines, masks as best defense against omicron variant
Nov 29, 2021
News reports out of South Africa noted that COVID-19 cases from omicron have resulted in mostly mild symptoms.
Pfizer set to ask FDA to approve booster for those 18 and older
Nov 09, 2021
Peter Chin-Hong, M.D., an infectious-disease physician at the University of California, San Francisco, said there is “some value” in young people getting a booster to protect older relatives...